KDL Biotech Ltd - Stock Price

  • NSE : KOPDRUGS
  • BSE : 532291
  • ISIN CODE : INE746A01010
  • Industry : Pharmaceuticals & Drugs
  • House : Parijat
KDL Biotech Ltd is not traded on BSE/NSE
NSE
2.10
0 %0
BSE
2.14
0 %0

Ratios

Parameter MAR 12  MAR 11  YoY %Change
Operational & Financial Ratios
   Earnings Per Share (Rs)-7.16-26.7673.24
   CEPS(Rs)-3.36-17.4680.75
   DPS(Rs)0.000.000.00
   Book NAV/Share(Rs)-24.62-17.46-41.02
   Tax Rate(%)0.00-13.59100.00
Margin Ratios
   Core EBITDA Margin(%)-7.58-56.3486.54
   EBIT Margin(%)-38.31-171.8277.71
   Pre Tax Margin(%)-63.15-195.0467.62
   PAT Margin (%)-63.15-221.5371.49
   Cash Profit Margin (%)-29.64-144.5579.49
Performance Ratios
   ROA(%)-28.21-78.5964.11
   ROE(%)0.000.000.00
   ROCE(%)-108.39-101.90-6.36
   Asset Turnover(x)0.450.3525.90
   Sales/Fixed Asset(x)0.180.19-6.23
   Working Capital/Sales(x)-0.26-0.3013.18
Efficiency Ratios
   Fixed Capital/Sales(x)5.695.336.64
   Receivable days2.082.29-9.20
   Inventory Days34.9238.80-9.98
   Payable days55.4896.71-42.63
Valuation Parameters
   PER(x)0.000.000.00
   PCE(x)-1.09-0.31-252.69
   Price/Book(x)-0.15-0.3151.85
   Yield(%)0.000.000.00
   EV/Net Sales(x)2.592.561.29
   EV/Core EBITDA(x)-52.39-4.53-1056.80
   EV/EBIT(x)-6.56-1.46-350.84
   EV/CE(x)1.211.118.77
   M Cap / Sales0.330.46-27.12
Growth Ratio
   Net Sales Growth(%)-6.83-25.9873.71
   Core EBITDA Growth(%)91.84-94.07197.63
   EBIT Growth(%)79.07-256.29130.85
   PAT Growth(%)73.24-278.13126.33
   EPS Growth(%)73.24-278.13126.33
Financial Stability Ratios
   Total Debt/Equity(x)-1.02-1.4328.94
   Current Ratio(x)0.060.06-5.45
   Quick Ratio(x)0.040.040.05
   Interest Cover(x)-1.54-7.4079.17
   Total Debt/Mcap(x)6.854.6447.57

Latest News

close